- Home
- GRND vs RXRX Comparison
GRND vs RXRX Comparison
Compare GRND & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRND | RXRX |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GRND | RXRX |
|---|---|---|
| Price | $14.64 | $3.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $20.40 | $7.32 |
| AVG Volume (30 Days) | 1.9M | ★ 20.9M |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 158.11 | 14.79 |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $439,898,000.00 | $74,681,000.00 |
| Revenue This Year | $27.79 | N/A |
| Revenue Next Year | $13.06 | $49.16 |
| P/E Ratio | $68.81 | ★ N/A |
| Revenue Growth | ★ 27.64 | 26.92 |
| 52 Week Low | $9.79 | $2.77 |
| 52 Week High | $18.50 | $5.24 |
Technical Indicators
Market Signals| Indicator | GRND | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.10 | 39.34 |
| Support Level | $14.40 | $2.90 |
| Resistance Level | $15.40 | $3.66 |
| Average True Range (ATR) | 0.62 | 0.32 |
| MACD | 0.21 | -0.07 |
| Stochastic Oscillator | 91.41 | 2.22 |
Price Performance
Historical ComparisonAbout GRND Grindr Inc.
Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discrete and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.